Vident Investment Advisory, LLC 10x Genomics, Inc. Transaction History

Vident Investment Advisory, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$50.96 - $58.72 $19,568 - $22,548	384 Added 6.16%	6,618 $369,000
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $220,247 - $347,794	6,234 New	6,234 $347,000
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $676,587 - $1.77 Million	-12,147 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $1,215 - $1,643	9 Added 0.07%	12,147 $1.81 Million
Q3 2021 Nov 12, 2021	SELL	$145.58 - $192.14 $122,869 - $162,166	-844 Reduced 6.5%	12,138 $1.77 Million
Q2 2021 Aug 13, 2021	BUY	$134.22 - $202.37 $2,013 - $3,035	15 Added 0.12%	12,982 $2.54 Million
Q1 2021 May 14, 2021	BUY	$140.25 - $196.86 $993,811 - $1.39 Million	7,086 Added 120.49%	12,967 $2.35 Million
Q4 2020 Feb 08, 2021	BUY	$126.47 - $163.7 $743,770 - $962,719	5,881 New	5,881 $833,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.53B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.